Utah Medical Products, Inc.
UTMD
$56.50
$1.021.83%
NASDAQ
| 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | |
|---|---|---|---|---|---|
| Net Income | 0.23% | 4.79% | -18.55% | 3.19% | -12.71% |
| Total Depreciation and Amortization | 5.13% | -1.23% | -1.35% | 6.78% | 1.46% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 53.68% | -202.26% | -- | 100.00% | 4.46% |
| Change in Net Operating Assets | -203.82% | 201.21% | -85.23% | 65.00% | -270.49% |
| Cash from Operations | -35.64% | 51.99% | -23.83% | 39.61% | -47.65% |
| Capital Expenditure | 72.28% | -1,944.44% | 89.89% | 19.09% | -400.00% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -100.00% |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | 100.00% | -- |
| Cash from Investing | 72.28% | -1,944.44% | 89.89% | 22.61% | -2,400.00% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | -- | -- | -- | -100.00% | 206.25% |
| Repurchase of Common Stock | -8.26% | 51.99% | -73.54% | 39.62% | -114.15% |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | 1.57% | 2.02% | 1.33% | 2.68% | 0.73% |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | -5.90% | 45.29% | -57.52% | 31.60% | -80.52% |
| Foreign Exchange rate Adjustments | 69.38% | 146.73% | -271.09% | 934.78% | 87.15% |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -428.37% | 106.37% | -613.95% | 83.29% | -588.19% |